Advertisement
Screener

STREAMEX CORP. (STEX) Preferred Stock Dividends, Income Statement Impact

2.8 / 5 stars · 68/120 Roast Me

STREAMEX CORP. Preferred Stock Dividends, Income Statement Impact

STREAMEX CORP. (STEX) reported Preferred Stock Dividends, Income Statement Impact of $174.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2026-03-31

  • STREAMEX CORP. preferred stock dividends, income statement impact for the quarter ending 2024-12-31 was $17.00K.
  • STREAMEX CORP. preferred stock dividends, income statement impact for the quarter ending 2024-09-30 was $24.00K.
  • STREAMEX CORP. preferred stock dividends, income statement impact for the quarter ending 2024-06-30 was $0.00.
  • STREAMEX CORP. preferred stock dividends, income statement impact for the quarter ending 2024-03-31 was $133.00K.
  • STREAMEX CORP. preferred stock dividends, income statement impact for fiscal 2024 was $174.00K.
  • STREAMEX CORP. preferred stock dividends, income statement impact for fiscal 2022 was $210.00K.
  • STREAMEX CORP. preferred stock dividends, income statement impact for fiscal 2021 was $0.00.
Period endPreferred Stock Dividends, Income Statement Impact 3 monthPreferred Stock Dividends, Income Statement Impact 6 monthPreferred Stock Dividends, Income Statement Impact 9 monthPreferred Stock Dividends, Income Statement Impact 12 month
2024-12-31$17.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$41.00K
derived: sum of 2 quarters · filed 2026-03-31
$41.00K
derived: sum of 3 quarters · filed 2026-03-31
$174.00K
10-K · filed 2026-03-31
2024-09-30$24.00K
10-Q · filed 2025-11-14
$24.00K
derived: sum of 2 quarters · filed 2025-11-14
$157.00K
10-Q · filed 2025-11-14
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15
$133.00K
10-Q · filed 2025-08-15
2024-03-31$133.00K
10-Q · filed 2025-05-19
2023-06-30$0.00
10-Q · filed 2023-08-14
$0.00
10-Q · filed 2023-08-14
2022-12-31$85.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
$102.00K
derived: sum of 2 quarters · filed 2024-04-16
$210.00K
derived: sum of 3 quarters · filed 2024-04-16
$210.00K
10-K · filed 2024-04-16
2022-09-30$17.00K
10-Q · filed 2023-11-14
$125.00K
derived: sum of 2 quarters · filed 2023-11-14
$125.00K
10-Q · filed 2023-11-14
2022-06-30$108.00K
10-Q · filed 2023-08-14
$108.00K
10-Q · filed 2023-08-14
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$0.00
derived: sum of 2 quarters · filed 2023-03-31
$0.00
derived: sum of 3 quarters · filed 2023-03-31
$0.00
10-K · filed 2023-03-31
2021-09-30$0.00
10-Q · filed 2022-11-14
$0.00
derived: sum of 2 quarters · filed 2022-11-14
$0.00
10-Q · filed 2022-11-14
2021-06-30$0.00
10-Q · filed 2022-08-15
$0.00
10-Q · filed 2022-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
IRIDEX CORP (IRIX)United States$0.011B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B